PDF herunterladen
CC BY-NC-ND 4.0 · International Journal of Epilepsy 2025; 11(01): 023-032
DOI: 10.1055/s-0044-1800960
Original Article

Impact of Vitamin D3 Deficiency on Quality of Life in Epilepsy: A Call for Routine Screening and Intervention

Sulena Sulena 
1   Division of Neurology, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India
,
Ishaan Parkash
2   Department of Psychiatry, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India
,
Pir Dutt Bansal
2   Department of Psychiatry, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India
,
Akanksha Nagar
1   Division of Neurology, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India
,
Dipti Gupta
3   Department of ENT, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India
,
Mamta Bahetra
2   Department of Psychiatry, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India
› Institutsangaben
Funding None.
› Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Abstract

Background The association between vitamin D3 levels and quality of life (QoL) in people with epilepsy on long-term antiseizure medications is an area of ongoing research. This study aims to assess serum vitamin D3 levels in people with epilepsy and evaluate the effects of supplementation on their QoL.

Materials and Methods A prospective study was conducted at a tertiary hospital from June 2021 to July 2022. People with epilepsy aged 12 to 45 years, receiving antiseizure medications for at least 1 year, were recruited. Baseline serum vitamin D3 levels were measured, and epilepsy diagnoses were confirmed according to the International League Against Epilepsy guidelines (2017). QoL was evaluated using the Quality of Life in Epilepsy Scale (QOLIE-31) for adults and the Quality of Life in Epilepsy for Adolescents Scale (QOLIE-48) for adolescents. Patients with vitamin D3 deficiencies received supplementation, and their QoL were reassessed at 3 and 6 months. Data were analyzed using t-tests, multiple logistic regression, and analysis of variance.

Results At baseline, the mean serum vitamin D3 level was 17.99 ± 6.77 ng/mL, increasing to 21.46 ± 2.91 ng/mL at 3 months and 24.41 ± 3.19 ng/mL at 6 months. Patients with vitamin D3 deficiency exhibited significantly lower scores across multiple domains of the Quality of Life Inventory (QOLIE-31 and QOLIE-48). A significant improvement was seen in most of the QOLIE scores and serum vitamin D3 levels after vitamin D3 supplementation.

Conclusion People with epilepsy on long-term antiseizure medications have vitamin D3 deficiency, which negatively impacts their QoL. Regular screening and supplementation are recommended for better management of epilepsy.

Keywords

epilepsy - vitamin D3 - quality of life - antiseizure medication - QOLIE-31 - QOLIE-48

Authors' Contributions

S.S., P.D., and I.P. conceptualized the study design; I.P. was responsible for the data collection and analysis; S.S. and P.D. supervised the data collection and analysis; I.P. prepared the first draft of the study; S.S., D.G., and A.N. revised the manuscript. All authors approved the final manuscript.


Supplementary Material



Publikationsverlauf

Artikel online veröffentlicht:
10. Januar 2025

© 2025. Indian Epilepsy Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Brodie MJ, French JA. Management of epilepsy in adolescents and adults. Lancet 2000; 356 (9226) 323-329
    CrossrefPubMedSuche in Google Scholar
  • 2 Baker GA, Jacoby A, Gorry J, Doughty J, Ellina V. SIGN Group. Quality of life of people with epilepsy in Iran, the Gulf, and Near East. Epilepsia 2005; 46 (01) 132-140
    CrossrefPubMedSuche in Google Scholar
  • 3 World Health Organization. Measuring Quality of Life: The World Health Organization Quality of Life Instruments (The WHOQOL-100 and the WHOQOL-BREF). Geneva, Switzerland:: World Health Organization;; 1997. . WHO/MSA/MNH/PSF/97.4
    Suche in Google Scholar
  • 4 Auriel E, Landov H, Blatt I. et al. Quality of life in seizure-free patients with epilepsy on monotherapy. Epilepsy Behav 2009; 14 (01) 130-133
    CrossrefPubMedSuche in Google Scholar
  • 5 Piperidou H, Terzoudi A, Vorvolakos T. et al. The Greek version of the Quality of Life in Epilepsy Inventory (QOLIE-31). Qual Life Res 2006; 15 (05) 833-839
    CrossrefPubMedSuche in Google Scholar
  • 6 Berto P. Quality of life in patients with epilepsy and impact of treatments. PharmacoEconomics 2002; 20 (15) 1039-1059
    CrossrefPubMedSuche in Google Scholar
  • 7 Meldolesi GN, Picardi A, Quarato PP. et al. Factors associated with generic and disease-specific quality of life in temporal lobe epilepsy. Epilepsy Res 2006; 69 (02) 135-146
    CrossrefPubMedSuche in Google Scholar
  • 8 Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK. Seizure frequency and the health-related quality of life of adults with epilepsy. Neurology 1999; 53 (01) 162-166
    CrossrefPubMedSuche in Google Scholar
  • 9 Fan HC, Lee HS, Chang KP. et al. The impact of anti-epileptic drugs on growth and bone metabolism. Int J Mol Sci 2016; 17 (08) 1242
    CrossrefPubMedSuche in Google Scholar
  • 10 Nicolaidou P, Georgouli H, Kotsalis H. et al. Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol 2006; 21 (03) 205-209
    CrossrefPubMedSuche in Google Scholar
  • 11 Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006; 47 (03) 510-515
    CrossrefPubMedSuche in Google Scholar
  • 12 Fong CY, Kong AN, Poh BK. et al. Vitamin D deficiency and its risk factors in Malaysian children with epilepsy. Epilepsia 2016; 57 (08) 1271-1279
    CrossrefPubMedSuche in Google Scholar
  • 13 Pendo K, DeGiorgio CM. Vitamin D3 for the treatment of epilepsy: basic mechanisms, animal models, and clinical trials. Front Neurol 2016; 7: 218
    CrossrefPubMedSuche in Google Scholar
  • 14 Aksoy D, Güveli BT, Ak PD, Sarı H, Ataklı D, Arpacı B. Effects of oxcarbazepine and levetiracetam on calcium, ionized calcium, and 25-OH vitamin-D3 levels in patients with epilepsy. Clin Psychopharmacol Neurosci 2016; 14 (01) 74-78
    CrossrefPubMedSuche in Google Scholar
  • 15 Fisher RS. The new classification of seizures by the International League Against Epilepsy 2017. Curr Neurol Neurosci Rep 2017; 17 (06) 48
    CrossrefPubMedSuche in Google Scholar
  • 16 Majumder S. Socioeconomic status scales: revised Kuppuswamy, BG Prasad, and Udai Pareekh's scale updated for 2021. J Family Med Prim Care 2021; 10 (11) 3964-3967
    CrossrefPubMedSuche in Google Scholar
  • 17 Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 1998; 39 (01) 81-88
    CrossrefPubMedSuche in Google Scholar
  • 18 Cramer JA, Westbrook LE, Devinsky O, Perrine K, Glassman MB, Camfield C. Development of the Quality of Life in Epilepsy Inventory for Adolescents: the QOLIE-AD-48. Epilepsia 1999; 40 (08) 1114-1121
    CrossrefPubMedSuche in Google Scholar
  • 19 Płudowski P, Karczmarewicz E, Bayer M. et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 2013; 64 (04) 319-327
    CrossrefPubMedSuche in Google Scholar
  • 20 Khadilkar A, Khadilkar V, Chinnappa J. et al. From Indian Academy of Pediatrics 'Guideline for Vitamin D and Calcium in Children' Committee.. Prevention and treatment of vitamin D and calcium deficiency in children and adolescents: Indian Academy of Pediatrics (IAP) guidelines. Indian Pediatr 2017; 54 (07) 567-573
    CrossrefPubMedSuche in Google Scholar
  • 21 Ciobanu AM, Petrescu C, Anghele C. et al. Severe vitamin D deficiency—a possible cause of resistance to treatment in psychiatric pathology. Medicina (Kaunas) 2023; 59 (12) 2056
    CrossrefPubMedSuche in Google Scholar
  • 22 Alhaidari HM, Babtain F, Alqadi K, Bouges A, Baeesa S, Al-Said YA. Association between serum vitamin D levels and age in patients with epilepsy: a retrospective study from an epilepsy center in Saudi Arabia. Ann Saudi Med 2022; 42 (04) 262-268
    CrossrefPubMedSuche in Google Scholar
  • 23 Mehndiratta MM, Kukkuta Sarma GR, Tripathi M. et al. A multicenter, cross-sectional, observational study on epilepsy and its management practices in India. Neurol India 2022; 70 (05) 2031-2038
    CrossrefPubMedSuche in Google Scholar
  • 24 Panagariya A, Sharma B, Dubey P, Satija V, Rathore M. Prevalence, demographic profile, and psychological aspects of epilepsy in North-Western India: a community-based observational study. Ann Neurosci 2018; 25 (04) 177-186
    CrossrefPubMedSuche in Google Scholar
  • 25 Teagarden DL, Meador KJ, Loring DW. Low vitamin D levels are common in patients with epilepsy. Epilepsy Res 2014; 108 (08) 1352-1356
    CrossrefPubMedSuche in Google Scholar
  • 26 Wu DY, Ding D, Wang Y, Hong Z. Quality of life and related factors in Chinese adolescents with active epilepsy. Epilepsy Res 2010; 90 (1-2): 16-20
    CrossrefPubMedSuche in Google Scholar
  • 27 Chaudhuri JR, Mridula KR, Rathnakishore C, Balaraju B, Bandaru VS. Association of 25-hydroxyvitamin D deficiency in pediatric epileptic patients. Iran J Child Neurol 2017; 11 (02) 48-56
    PubMedSuche in Google Scholar
  • 28 Pimpalkhute SA, Bajait CS, Dakhale GN, Sontakke SD, Jaiswal KM, Kinge P. Assessment of quality of life in epilepsy patients receiving anti-epileptic drugs in a tertiary care teaching hospital. Indian J Pharmacol 2015; 47 (05) 551-554
    CrossrefPubMedSuche in Google Scholar
  • 29 Sureka RK, Yadav KS, Agrawal R, Nijhawan M. Quality of life in patients with epilepsy: study from a Northern Indian teaching hospital. J Mahatma Gandhi Univ Med Sci Tech. 2017; 2: 10-13
    PubMedSuche in Google Scholar
  • 30 Nagarathnam M, Shalini B, Vijayalakshmi V, Vengamma B, Latheef SAA. Predictors of quality of life among adolescents with epilepsy in the state of Andhra Pradesh. Neurol India 2017; 65 (05) 1019-1024
    CrossrefPubMedSuche in Google Scholar
  • 31 Siqueira NF, Oliveira FL, Siqueira JA, de Souza EA. Quality of life in epilepsy: a study of Brazilian adolescents. PLoS One 2014; 9 (09) e106879
    CrossrefPubMedSuche in Google Scholar
  • 32 Salih AI, Mahmood IH, Alkhaffaf WH. Effect of vitamin D level on quality of life in epileptic patients. J Health Sci 2021; 44 (06) 2979-2988
    PubMedSuche in Google Scholar
  • 33 Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167 (16) 1730-1737
    CrossrefPubMedSuche in Google Scholar
  • 34 Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol Scand 2004; 110 (04) 207-220
    CrossrefPubMedSuche in Google Scholar
  • 35 Chassoux F, Navarro V, Quirins M. et al. Vitamin D deficiency and effect of treatment on seizure frequency and quality of life parameters in patients with drug-resistant epilepsy: a randomized clinical trial. Epilepsia 2024; 65 (09) 2612-2625
    CrossrefPubMedSuche in Google Scholar
  • 36 Lee SH, Yu J. Risk factors of vitamin D deficiency in children with epilepsy taking anticonvulsants at initial and during follow-up. Ann Pediatr Endocrinol Metab 2015; 20 (04) 198-205
    CrossrefPubMedSuche in Google Scholar